Prestige Consumer Healthcare (PBH) Other Operating Expenses (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Other Operating Expenses came in at $45.2 million in Q4 2025, up 5.36% year-on-year from $42.9 million in Q4 2024, and up 3.04% quarter-over-quarter from $43.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Operating Expenses (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Operating Expenses history runs 14 years deep, the most recent figure standing at $45.2 million for Q4 2025.
- On a quarterly basis, Other Operating Expenses rose 5.36% year-over-year to $45.2 million in Q4 2025; TTM through Dec 2025 was $183.7 million, a 3.13% increase from a year earlier, with the FY2025 full-year figure at $189.5 million, up 7.74% from the prior year.
- Other Operating Expenses advanced to $45.2 million in Q4 2025 per PBH's latest filing, from $43.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $407.1 million in Q1 2023 and bottomed at $36.7 million in Q4 2022.
- The 5-year median for Other Operating Expenses is $45.2 million (2021), against an average of $63.1 million.
- Across the five-year window, Other Operating Expenses jumped 811.05% in 2023 and plunged 89.39% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at $46.5 million in 2021, then retreated by 21.09% to $36.7 million in 2022, then grew by 22.96% to $45.1 million in 2023, then decreased by 4.87% to $42.9 million in 2024, then gained by 5.36% to $45.2 million in 2025.
- Per Business Quant, the three latest PBH Other Operating Expenses figures stand at $45.2 million (Q4 2025), $43.9 million (Q3 2025), and $40.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.20 Mn |
| Sep 30, 2025 | 43.87 Mn |
| Jun 30, 2025 | 40.12 Mn |
| Mar 31, 2025 | 54.53 Mn |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 46.98 Mn |
| Jun 30, 2024 | 45.07 Mn |
| Mar 31, 2024 | 43.20 Mn |
| Dec 31, 2023 | 45.10 Mn |
| Sep 30, 2023 | 45.77 Mn |
| Jun 30, 2023 | 41.79 Mn |
| Mar 31, 2023 | 407.10 Mn |
| Dec 31, 2022 | 36.68 Mn |
| Sep 30, 2022 | 50.19 Mn |
| Jun 30, 2022 | 46.39 Mn |
| Mar 31, 2022 | 44.68 Mn |
| Dec 31, 2021 | 46.48 Mn |
| Sep 30, 2021 | 46.90 Mn |
| Jun 30, 2021 | 45.20 Mn |
| Mar 31, 2021 | 44.73 Mn |